CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA
|
0.730 |
Biomarker
|
disease |
BEFREE |
These phenotypes range from Leigh and West syndrome to a new syndrome abbreviated CAGSSS that is characterised by cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, as well as cataract with no additional anomalies.
|
30419932 |
2018 |
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
IARS2 mutations are reported to cause Leigh syndrome or cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysphasia syndrome (CAGSSS).
|
30041933 |
2018 |
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Here we report a case of two Japanese siblings with Leigh syndrome, some features of CAGSSS, and West syndrome that are found to have compound heterozygous novel IARS2 mutations.
|
30041933 |
2018 |
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
These phenotypes range from Leigh and West syndrome to a new syndrome abbreviated CAGSSS that is characterised by cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, as well as cataract with no additional anomalies.
|
30419932 |
2018 |
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Confirmation of CAGSSS syndrome as a distinct entity in a Danish patient with a novel homozygous mutation in IARS2.
|
28328135 |
2017 |
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
Confirmation of CAGSSS syndrome as a distinct entity in a Danish patient with a novel homozygous mutation in IARS2.
|
28328135 |
2017 |
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Recessive Mutation in a Nuclear-Encoded Mitochondrial tRNA Synthetase Associated With Infantile Cataract, Congenital Neurotrophic Keratitis, and Orbital Myopathy.
|
27078007 |
2016 |
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutation in the nuclear-encoded mitochondrial isoleucyl-tRNA synthetase IARS2 in patients with cataracts, growth hormone deficiency with short stature, partial sensorineural deafness, and peripheral neuropathy or with Leigh syndrome.
|
25130867 |
2014 |
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutation in the nuclear-encoded mitochondrial isoleucyl-tRNA synthetase IARS2 in patients with cataracts, growth hormone deficiency with short stature, partial sensorineural deafness, and peripheral neuropathy or with Leigh syndrome.
|
25130867 |
2014 |
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA
|
0.730 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutation in the nuclear-encoded mitochondrial isoleucyl-tRNA synthetase IARS2 in patients with cataracts, growth hormone deficiency with short stature, partial sensorineural deafness, and peripheral neuropathy or with Leigh syndrome.
|
25130867 |
2014 |
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
Mutation in the nuclear-encoded mitochondrial isoleucyl-tRNA synthetase IARS2 in patients with cataracts, growth hormone deficiency with short stature, partial sensorineural deafness, and peripheral neuropathy or with Leigh syndrome.
|
25130867 |
2014 |
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA
|
0.730 |
Biomarker
|
disease |
CTD_human |
|
|
|
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA
|
0.730 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Leigh Disease
|
0.430 |
Biomarker
|
disease |
CLINGEN |
Here we report a case of two Japanese siblings with Leigh syndrome, some features of CAGSSS, and West syndrome that are found to have compound heterozygous novel IARS2 mutations.
|
30041933 |
2018 |
Leigh Disease
|
0.430 |
GeneticVariation
|
disease |
BEFREE |
IARS2 mutations are reported to cause Leigh syndrome or cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysphasia syndrome (CAGSSS).
|
30041933 |
2018 |
Leigh Disease
|
0.430 |
Biomarker
|
disease |
CLINGEN |
Mitochondrial DNA transcription and translation: clinical syndromes.
|
29980628 |
2018 |
Leigh Disease
|
0.430 |
Biomarker
|
disease |
BEFREE |
IARS2 (OMIM 612801) encodes the mitochondrial isoleucine-tRNA synthetase which belongs to the class-I aminoacyl-tRNA synthetase family, and has been implicated in CAGSSS and a form of Leigh syndrome.
|
28328135 |
2017 |
Leigh Disease
|
0.430 |
Biomarker
|
disease |
CLINGEN |
Proteomics. Tissue-based map of the human proteome.
|
25613900 |
2015 |
Leigh Disease
|
0.430 |
CausalMutation
|
disease |
CLINVAR |
Compound heterozygous mutations in IARS2 were independently identified in a previously unreported patient with a more severe mitochondrial phenotype diagnosed as Leigh syndrome.
|
25130867 |
2014 |
Leigh Disease
|
0.430 |
Biomarker
|
disease |
CLINGEN |
Compound heterozygous mutations in IARS2 were independently identified in a previously unreported patient with a more severe mitochondrial phenotype diagnosed as Leigh syndrome.
|
25130867 |
2014 |
Leigh Disease
|
0.430 |
GeneticVariation
|
disease |
BEFREE |
Compound heterozygous mutations in IARS2 were independently identified in a previously unreported patient with a more severe mitochondrial phenotype diagnosed as Leigh syndrome.
|
25130867 |
2014 |
LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Novel IARS2 mutations in Japanese siblings with CAGSSS, Leigh, and West syndrome.
|
30041933 |
2018 |
LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Mitochondrial DNA transcription and translation: clinical syndromes.
|
29980628 |
2018 |
Leigh Syndrome Due To Mitochondrial Complex II Deficiency
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Novel IARS2 mutations in Japanese siblings with CAGSSS, Leigh, and West syndrome.
|
30041933 |
2018 |
Leigh Syndrome Due To Mitochondrial Complex II Deficiency
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Mitochondrial DNA transcription and translation: clinical syndromes.
|
29980628 |
2018 |